Work

Supplementary Figure 3 from Quantitative DNA Repair Biomarkers and Immune Profiling for Temozolomide and Olaparib in Metastatic Colorectal Cancer

Year: 2023

Type: supplementary-materials

Abstract: Supplementary Figure 3: Changes in MGMT expression, yH2AX and CD8+ T cells in pre-treatment and post-treatment biopsies of patients who derived clinical benefit from the trial.

DOI: 10.1158/2767-9764.23593094

Authors: Michael Cecchini, Janie Y. Zhang, Wei Wei, Jeffrey Sklar, Jill Lacy, Minghao Zhong, Yong Kong, Hongyu Zhao, Jassim DiPalermo, Lesley Devine, Stacey M. Stein, Jeremy Kortmansky, Kimberly L. Johung, Ranjit S. Bindra, Patricia LoRusso, Kurt A. Schalper

Language: English

Topic: Colorectal Cancer Treatments and Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4382498977

Cites:

Cited by:

Related to: 10